相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
Erik Ingelsson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Leukotriene B4 Receptor-1 Mediates Intermittent Hypoxia-induced Atherogenesis
Richard C. Li et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
Jesper Z. Haeggstrom et al.
CHEMICAL REVIEWS (2011)
Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury
Ulrich M. Becher et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
A Selective Cysteinyl Leukotriene Receptor 2 Antagonist Blocks Myocardial Ischemia/Reperfusion Injury and Vascular Permeability in Mice
Nathan C. Ni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Advances in eicosanoid research, novel therapeutic implications
Jesper Z. Haeggstrom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
Daniel Poeckel et al.
CARDIOVASCULAR RESEARCH (2010)
Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice
Richard Yang Cao et al.
ATHEROSCLEROSIS (2009)
Increased urinary leukotriene E4 excretion in obstructive sleep apnea: Effects of obesity and hypoxia
Francoise Stanke-Labesque et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4
Akiko Maekawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury
Wei Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors
Akiko Maekawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Atherosclerosis - The path from genomics to therapeutics
David T. Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability
Hong Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction
A Helgadottir et al.
NATURE GENETICS (2006)
Leukotriene modifiers as potential therapeutics for cardiovascular disease
CD Funk
NATURE REVIEWS DRUG DISCOVERY (2005)
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice
YX Wang
NEUROBIOLOGY OF AGING (2005)
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
A Helgadottir et al.
NATURE GENETICS (2004)
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis
JH Dwyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Enzymes and receptors in the leukotriene cascade
JZ Haeggström et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
